Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF) Given Average Recommendation of “Reduce” by Analysts

Posted by Nicole Kennedy on Jun 21st, 2026

Shares of Beiersdorf Aktiengesellschaft (OTCMKTS:BDRFF – Get Free Report) have been assigned a consensus recommendation of “Reduce” from the six ratings firms that are covering the stock, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation and four have given a hold recommendation to the company.

Several analysts have commented on BDRFF shares. UBS Group raised shares of Beiersdorf Aktiengesellschaft from a “sell” rating to a “neutral” rating in a research report on Tuesday, March 31st. Morgan Stanley lowered shares of Beiersdorf Aktiengesellschaft from an “equal weight” rating to an “underweight” rating in a research report on Monday, March 16th. Berenberg Bank reissued a “hold” rating on shares of Beiersdorf Aktiengesellschaft in a research report on Monday, March 23rd. JPMorgan Chase & Co. reissued a “neutral” rating on shares of Beiersdorf Aktiengesellschaft in a research report on Wednesday, March 18th. Finally, Royal Bank Of Canada downgraded shares of Beiersdorf Aktiengesellschaft from a “sector perform” rating to an “underperform” rating in a report on Tuesday, March 10th.

Check Out Our Latest Stock Analysis on BDRFF

Beiersdorf Aktiengesellschaft Price Performance

BDRFF stock opened at $83.72 on Friday. The firm has a 50-day simple moving average of $84.25 and a two-hundred day simple moving average of $97.74. Beiersdorf Aktiengesellschaft has a one year low of $79.77 and a one year high of $129.88.

About Beiersdorf Aktiengesellschaft

(Get Free Report)

Beiersdorf Aktiengesellschaft is a global consumer goods company headquartered in Hamburg, Germany, with a history dating back to its founding in 1882 by pharmacist Paul C. Beiersdorf. The company is best known for its skincare brands, including NIVEA, Eucerin, La Prairie and Labello, as well as its tesa division, which produces self-adhesive products and industrial tapes. Over its long history, Beiersdorf has built a reputation for innovation in dermatological research and product development, introducing pioneering formulations that span mass-market and premium segments.

The company’s operations are organized into two main business divisions.